Össur reports 23% EBITDA

Össur reports 23% EBITDA

3rd Q 2009 Sales USD 84 million Strong prosthetics sales, growing 11% EBITDA margin 23% Net profit 7% of sales Second generation of RHEO KNEE extremely well received GPO contract in the US [...]

READ MORE